Drug Research
Bayer and Exscientia collaborate to leverage the potential of AI in cardiovascular and oncology drug discovery
Bayer and Exscientia Ltd., a UK-based Artificial Intelligence (AI)-driven drug discovery company, have entered into a three-year, multi-target collaboration. The partners will work on...
Press Releases
Mundipharma enters partnership with Samsung Bioepis to expand biosimilars into Hong Kong and Taiwan
Mundipharma announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis’ first-wave biosimilar candidates in Taiwan and Hong Kong.
The partnership covers Samsung Bioepis’ biosimilar...
News
RenaSci bolsters kidney disease and fibrosis capabilities with senior appointment
Leading in vivo pharmacology and consultancy services firm RenaSci, part of the Sygnature Group, have bolstered their Kidney Disease and Fibrosis capabilities with the...
Drug Research
Development of First-In-Class Antibody Therapeutics and New Acquisition Brings Hope to Patients with Fibrotic and Inflammatory Diseases
The breakthrough discovery of investigational therapies for multiple human diseases by a team of Singapore clinicians, clinician scientists and scientists from National Heart Centre...
Press Releases
BioAsia to promote innovations in Life Science and Healthcare through Start-up Stage in its 17th Edition
Asia's largest Life-sciences and healthcare forum BioAsia, will continue to feature a dedicated platform - Start-up Stage in its 17th edition to be held...
Clinical Trials
Signant Health Partners with Propeller Health to Gather Accurate Data on Asthma and COPD Medication Use
Signant Health announced a partnership to connect TrialMax®, the industry-leading electronic Clinical Outcome Assessment (eCOA) platform, to Propeller Health’s digital health platform for asthma...
Press Releases
Amgen commences strategic collaboration with BeiGene to expand oncology presence in China
Amgen announced the successful closing of the transaction to enter into a strategic collaboration with BeiGene that will significantly accelerate Amgen's plans to expand...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read